ArticleBlood cancer journal2023

DNA-PK hyperactivation occurs in deletion 11q chronic lymphocytic leukemia and is both a biomarker and therapeutic target for drug-resistant disease.

Sara E F Kost et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.